A former White House adviser who pushed malaria drugs as a treatment for COVID-19 long after the FDA had ruled them out has ...

Yes, according to leading vaccine physician Paul Offit, who denounced the new placebo-controlled trial requirements for ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

HHS implemented a pause on research of deadly infectious diseases at one of the nation's most highly secure research labs, ...

A spokesman for HHS also did not respond to a request for ... data” has shown that hydroxychloroquine “doesn’t cure covid and has risks.” “My hope is that Dr. Hatfill will pursue the ...

The advisory committee meeting is an important step in the process of readying boosters for the fall and winter season, but will take place amid newly imposed scrutiny of COVID shots.

The Department of Health and Human Services said it is redirecting funding from what it calls a wasteful Biden-era project on ...

The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a ...

"As the agency continues to streamline operations, the essential services provided by NIOSH will remain fully intact and ...

While Vaxart can proceed with its study, fellow COVID-19 vaccine developers GeoVax and Novavax continue to be hamstrung by ...

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next ...

A similar paradigm has unfolded for Covid-19 vaccines since they were first authorized in the height of the pandemic at the end of 2020. HHS’s new initiative also aims to develop universal ...